“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
“OtoSet: Sonicare for the Ears” An Arizona-based medical device start-up SafKan Inc is pursuing an alternative to the current standard-of-care for excess or impacted earwax— unchallenged for nearly two centuries—with the world’s first automated ear cleaning device for clinical use, the OtoSet. In this interview, co-founder and CEO Sahil Diwan talks about his experiences in co-founding the company and what’s next for SafKan.
“When One Door Closes Another Door Opens: The Story of Telluride Medical Partners.” Emerging Arizona-based medical device accelerator Telluride Medical Partners LLC (TMP) is comprised of business entrepreneurs, medical device start-up experts, and medtech engineers who are committed to bringing disruptive technologies to market. In this candid interview, Founder and CEO Eric Wells talks about his early career, his experiences in founding the company, and what’s next for TMP.
In this new installment of his series of interviews on corporate governance in medtech, DeNovo Ventures’ Managing Director Joe Mandato speaks with Jay Watkins, also a Managing Director at De Novo Ventures and at Curation Capital. Jay has served in multiple board roles and shares his insights on what makes a good board tick.
“Sana’s Wearable Solution for Chronic Pain” Boulder, CO-based start-up Sana Health is taking on one of the biggest health crises in the world today: opioid use, as part of a larger mission to redefine the way pain is treated. Sana’s novel FlowState technology induces deep relaxation, promotes neuroplasticity, reduces pain, and triggers sleep in as little as 10 minutes. In this interview, Founder Richard Hanbury talks about his experiences in founding the company and what’s next for Sana Health.
As noted in previous posts here on the Community Blog, dialysis is a therapy whose time has come, and disruptive innovation is needed. In a first-of-its-kind partnership between the US Department of Health and Human Services and the American Society of Nephrology, the ongoing KidneyX: Redesign Dialysis prize competition is looking to spur medtech innovation that completely disrupts the way kidney failure is treated.
Driven by his passion to take care of the people who willingly put their lives on the line, Medical Technology Enterprise Consortium’s COO, William Howell, talks to the Community Blog about the goals of MTEC, and cutting-edge biomedical research that has recently received funding through this US Army organization. Although research is primarily focused on restoring function to severely injured soldiers, many of the medical technologies originally developed by or with funding support from the US military are also impacting the lives of millions of civilian patients.
“Billy Cohn, MD: Making Medtech Makers at Johnson & Johnson’s CDI @TMC” In this candid video interview onsite at the Center for Device Innovation in Houston, TX, Billy Cohn, MD, VP of Johnson & Johnson’s Medical Device Companies and Director, CDI @ TMC reflects on his extensive device patent journey and shares the keys to overcoming the never-ending challenges that plague device innovation.
As the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes it, vascular access is so important to a hemodialysis patient that it can be considered a ‘lifeline.’ However, this vital access site is prone to stenosis, thrombosis, and costly re-interventions. Laminate Medical Technologies hopes to support this critical lifeline with a first-of-its-kind external support device for AV fistulas, that alleviates wall tension and regulates an undesired narrowing of the vein and/or frequent blockages of the blood vessels.
End-stage renal disease treatment is a little known but dominant cost driver for the global healthcare system, and the number of patients needing regular dialysis in order to stay alive—and repeated interventions to combat complications—is growing. With its origins as a blood-filtering machine devised from tin cans, sausage casings and other non-medical parts by a determined Dutch physician in World War II Netherlands, today medical device companies such as Healionics are working to address the most critical and costly unmet need in dialysis: maintaining healthy and functional access to the bloodstream.
There are about 466 million people worldwide with disabling hearing loss, 48 million of them in the US. To date, hearing aid devices have been the only solution to sensorineural hearing loss, the kind that comes from aging and the damage loud sounds cause. Eyeing the potential blockbuster opportunity, pharmaceutical companies like Decibel Therapeutics have finally joined the fray.
PAH, a progressive, incurable disease leading to right heart failure that strikes mostly women in the prime of life, has limited treatment options beyond some of the most expensive drugs covered by Medicare. TCT 2018 Shark Tank winner Aria CV hopes to impact the poor prognosis for this disease by focusing its first-of-a-kind, fully implantable device on a fundamental new mechanism of action—mimicking the function of a healthy pulmonary artery.
“FineHeart: A Disruptively Simple Solution for Advanced Heart Failure” France-based FineHeart SA aims to make an impact on the second leading cause of death in the US and in Europe: heart failure (HF) with its first patented product ICOMS. The ICOMS is a hybrid system composed of a pulsatile smart pump, an electrical synchronization module, a control board, and an energy module powered by a TET system. In this interview, CEO Arnaud Mascarell talks about his early inspiration, his experiences in co-founding the company and what’s next for FineHeart.
Behemoth online retailer Amazon is setting its powerful sights on the medical device supply chain. Will the Internet giant have the resolve to invest in the competencies and infrastructure necessary to meet the regulatory demands of healthcare logistics? It faces a number of tailwinds and headwinds in its run at disrupting the healthcare market, says Larry Smith, retired Vice President, Global Supply Chain at BD.
Innovation in the device space isn’t just about next-generation technologies—it also defines the forward-thinking role of today’s medical device supply chain. Here, we look at three key issues impacting supply chain organizations that companies of all sizes need to pay attention to as they grow, expand into developing markets, and as the industry consolidates, according to industry veteran Larry Smith, retired VP, Global Supply Chain at BD. One potential game-changer on the horizon: Amazon.